Several organizations have completely outsourced their entire pharmacovigilance functions to dedicated service providers in anticipation of being able to benefit from economies of scale that vendors promise. Nevertheless, Pharmacovigilance departments still face several unique challenges. This paper delves into some of the challenges and how they affect multiple roles within the pharmacovigilance and safety departments of life sciences organizations.

[contact-form-7 id="41" title="download the White Paper Default"]